Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
23 hedge funds and large institutions have $4.35M invested in Celgene Corporation Contingent Value Rights in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
6% more capital invested
Capital invested by funds: $4.11M → $4.35M (+$243K)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
4% less funds holding
Funds holding: 24 → 23 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$72.8K |
| 2 |
DC
Davenport & Co
Richmond,
Virginia
|
+$64.7K |
| 3 |
Morgan Stanley
New York
|
+$14.2K |
| 4 |
MSTVIM
Messner & Smith Theme Value Investment Management
San Diego,
California
|
+$6.88K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$3.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$841K |
| 2 |
Citigroup
New York
|
-$70.8K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$10.8K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.25K |
CELGZ Hedge Fund Activity: Q3 2014 in Review
23 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q3 2014, worth a combined $4.35M — up 5.9% from $4.11M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CELGZ and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Cannell & Co, opening a new position worth an estimated $72.8K. The largest seller was FCG Advisors, exiting entirely with an estimated $841K sold.
- 23 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q3 2014, down from 24 in Q2 2014.
- Funds reported $4.35M of Celgene Corporation Contingent Value Rights stock for Q3 2014, up 5.9% quarter-over-quarter.
- 2 funds opened new Celgene Corporation Contingent Value Rights positions in Q3 2014 and 3 closed out, a net change of -1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q3 2014 was Cannell & Co, an estimated $72.8K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q3 2014 was FCG Advisors, an estimated $841K sold.
Based on aggregated 13F filings for Q3 2014.